Health
No benefit from virus blood plasma: study – The West Australian
A trial looking at whether blood plasma from COVID-19 patients can help those who are seriously ill does not appear to work in ICU patients, researchers say.
An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators say.
The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product – an antibody-rich plasma taken from people who have recovered from the pandemic…
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business20 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General17 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year